NCT01595854View on ClinicalTrials.gov

Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy
Interventions
DRUG

dabigatran etexilate

medium dose dabigatran

DRUG

Ticagrelor

high dose ticagrelor

DRUG

Ticagrelor

high dose ticagrelor

DRUG

dabigatran etexilate

low dose dabigatran

DRUG

dabigatran etexilate

medium dose dabigatran

Trial Locations (1)

Unknown

1160.141.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01595854 - Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran | Biotech Hunter | Biotech Hunter